A Phase I Clinical Study of ER2001 Injection for the Treatment of Early Manifest Huntington's Disease.
Clinical trial NCT07339514 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07339514
- Sponsor
- ExoRNA Bioscience
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-11
- Primary completion
- 2026-04-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.